BDBM402095 N-{2-[(4-cyanopyridin-2- yl)(methyl)amino]ethyl}-N- ethyl-2-pyrazin-2- ylbenzamide::US10011595, F-11

SMILES CCN(CCN(C)c1cc(ccn1)C#N)C(=O)c1ccccc1-c1cnccn1

InChI Key InChIKey=PSSIJKHEXHFQFB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 402095   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402095(US10011595, F-11 | N-{2-[(4-cyanopyridin-2- yl)(me...)
Affinity DataIC50: 23nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402095(US10011595, F-11 | N-{2-[(4-cyanopyridin-2- yl)(me...)
Affinity DataIC50: 1.00E+4nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent